Abstract
Antiepileptic drug exposure in utero may have adverse effects on the developing brain, as has been shown in experimental animals. Exposure in the first trimester of human pregnancy may be associated with the occurrence of physical malformations in the foetus but, in addition, foetal valproate exposure poses a significant risk for the cognitive development of the infant, an effect that is dose dependent. Carbamazepine and lamotrigine exposures appear to hold a lesser risk for cognitive development, while the risks associated with exposure to the other antiepileptic drugs are uncertain. Further, evidence has become available that intrauterine valproate exposure may be associated with the development of autism-spectrum disorder in childhood. Not enough data exists to clarify the situation in this regard for the other antiepileptic drugs.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Adab N, Kini U, Vinten J et al (2004) The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 75:1575–1583
Asimiadou S, Bittigau P, Felderhoff-Mueser U et al (2005) Protection with estradiol in developmental models of apoptotic neurodegeneration. Ann Neurol 58:266–276
Baker GA, Bromley RL, Brigg SM et al (2015) IQ at 6 years after in utero exposure to antiepileptic drugs. A controlled cohort study. Neurology 84:382–390
Bergman A, Feigenbaum JJ, Yanai J (1982) Neuronal losses in mice following both prenatal and neonatal exposure to phenobarbital. Acta Anat 114:185–192
Bittigau P, Sifringer M, Genz K et al (2002) Aeds and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci U S A 99:15089–15094
Bittigau P, Sifringer M, Ikonomidou C (2003) Antiepileptic drugs and apoptosis. Ann NY Acad Sci 993:103–114
Blom HJ, Shaw GM, den Heijer MS, Finnell RH (2006) Neural tube defects and folate; case far from closed. Nat Rev Neurosci 7:724–731
Bolanos AR, Sarkisian M, Yang Y et al (1998) Comparison of valproate and phenobarbital treatment after status epilepticus in rats. Neurology 51:41–48
Bromley RL, Mawer G, Clayton-Smith J, Baker GA, Liverpool and Manchester Neurodevelopment Group (2008) Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology 71:1923–1924
Christianson AL, Chesler N, Kromberg JG (1994) Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs. Dev Med Child Neurol 36:361–369
Cummings C, Stewart M, Stevenson M, Morrow J, Nelson J (2011) Neurodevelopment of children exposed to lamotrigine, sodium valproate and carbamazepine. Arch Dis Child 96:643–647
Deblay MF, Vert P. André M (1982) Children of epileptic mothers. Nouv Presse Med 11: 173–176
Delgado-Escueta AV, Janz D (1992) Consensus guidelines: preconception counselling, management, and care of the pregnant woman with epilepsy. Neurology 42(4 Suppl 5):149–160
Diaz J, Schain RJ (1978) Phenobarbital: effects of long-term administration on behavior and brain of artificially reared rats. Science 199:90–91
Dodrill CB, Wilensky AJ (1992) Neuropsychological abilities before and after 5 years of stable antiepileptic drug therapy. Epilepsia 33:327–334
Downing C, Biers J, Larson C et al (2010) Genetic and maternal effects on valproic acid teratogeness in C57BL/6J and DBA/2J mice. Toxicol Sci 116:632–639
Eriksson K, Viinikainen K, Mönkkönen A, Aikiä M, Nieminen P, Heinonen S, Kälviäinen R (2005) Children exposed to valproate in utero – population based evaluation of risks and confounding factors for long-term neurocognitive development. Epilepsy Res 65:189–200
Farwell JR, Lee YJ, Hirtz DG, Sulzbacher SI, Ellenberg JH, Nelson KB (1990) Phenobarbital for febrile seizures – effects on intelligence and on seizure recurrence. N Engl J Med 322:364–369. Erratum in: N Engl J Med (1992); 326:144
Fishman RH, Ornoy A, Yanai J (1983) Ultrastructural evidence of long-lasting cerebellar degeneration after early exposure to phenobarbital in mice. Exp Neurol 79:212–222
Gaily E, Kantola-Sorsa F, Granstrom MI (1988) Intelligence of children of epileptic mothers. J Pediatr 113:677–684
Gaily EK, Granström ML, Hiilesmaa VK, Bardy AH (1990) Head circumference in children of epileptic mothers: contributions of drug exposure and genetic background. Epilepsy Res 5:217–222
Gaily E, Kantola-Sorsa F, Hiilesmaa V et al (2004) Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 62:28–32
Gedzelman E, Meador KJ (2012) Aeds in women with epilepsy during pregnancy. Ther Adv Drug Saf 3:71–87
Glier C, Dzietko M, Bittigau P, Jarosz B, Korobowicz E, Ikonomidou C (2004) Therapeutic doses of topiramate are not toxic to the developing rat brain. Exp Neurol 187:403–409
Hanson JW, Myrianthopoulos NC, Harvey MA, Smith DW (1976) Risk to the offspring of women treated with hydantoin anticonvulsants, with emphasis on fetal hydantoin syndrome. J Pediatr 89:662–668
Hiilesmaa V (1996) Effects of maternal seizures on the fetus. In: Tomson T, Gram L, Sillanpaa M, Johanessen S (eds) Epilepsy and pregnancy. Wrightson Biomedical Publishing, Peterfield, pp 135–141
Holmes LB, Rosenberger PB, Harvey EA, Khoshbin S, Ryan L (2000) Intelligence and physical features of children of women with epilepsy. Teratology 61:196–202
Ikonomidou C, Turski L (2010) Aeds and brain development. Epilepsy Res 88:11–22
Ikonomidou C, Scheer I, Wilhelm T et al (2007) Brain morphology alterations in the basal ganglia and the hypothalamus following prenatal exposure to antiepileptic drugs. Eur J Paediatr Neurol 11:297–301
Kaindl AM, Asimiadou S, Manthey D, Hagen MV, Turski L, Ikonomidou C (2006) Aeds and the developing brain. Cell Mol Life Sci 63:399–413
Katz I, Kim J, Gale K, Kondratyev A (2007) Effects of lamotrigine alone and in combination with MK-801, phenobarbital, of phenytoin on cell death in the neonatal rat brain. J Pharmacol Exp Ther 322:494–500
Kaufman AS (1990) Assessing adolescent and adult intelligence. Allyn & Bacon, Boston
Kim J, Kondratyev A, Gale K (2007) Antiepileptic drug-induced neuronal cell death in the immature brain: effects of carbamazepine, topiramate, and levetiracetam as monotherapy versus polytherapy. J Pharmacol Exp Ther 323:165–173
Loring DW, Meador KJ (2001) Cognitive and behavioral effects of epilepsy treatment. Epilepsia 42(Suppl 8):24–32
Majewski F, Steger M, Richter B, Gill J, Rabe F (1981) The teratogenicity of hydantoins and barbiturates in humans, with considerations on the etiology of malformations and cerebral disturbances in the children of epileptic parents. Int J Biol Res Pregnancy 2:37–45
Manthey D, Asimiadou S, Stefovska V et al (2005) Sulthiame but not levetiracetam exerts neurotoxic effect in the developing rat brain. Exp Neurol 193:497–503
Meador KJ (2005) Cognitive effects of epilepsy and of antiepileptic medications. In: Wyllie E (ed) The treatment of epilepsy. Principles and practices, 4th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1185–1195
Meador KJ, Gilliam FG, Kanner AM, Pellock JM (2001) Cognitive and behavioral effects of antiepileptic drugs. Epilepsy Behav 2:SS1–SS17
Meador KJ, Baker G, Cohen MJ, Gaily E, Westerveld M (2007) Cognitive/behavioral teratogenetic effects of antiepileptic drugs. Epilepsy Behav 11:292–302
Meador K, Reynolds MW, Crean S, Fahrbach K, Probst C (2008) Pregnancy outcomes in women with epilepsy: a systematic review and analysis of published pregnancy registers and cohorts. Epilepsy Res 81:1–13
Meador KJ, Baker GA, Browning N et al (2009) Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med 360:1597–1605
Meador KJ, Baker GA, Browning N et al (2013) Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol 12:244–252
Mikati MA, Holmes GL, Chronopoulos A et al (1994) Phenobarbital modifies seizure-related brain injury in the developing brain. Ann Neurol 36:425–433
Molgaard-Nielsen D, Hviid A (2011) Newer-generation antiepileptic drugs and the risk of major birth defects. JAMA 305:1996–2002
Moore SJ, Turnpenny P, Quinn A, Glover S, Lloyd DJ, Montgomery T, Dean JC (2000) A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet 37:489–497
Nadebaum C, Anderson V, Vajda F, Reutens D, Barton S, Wood A (2011a) The Australian brain and cognition and antiepileptic drugs study: IQ in school-aged children exposed to sodium valproate and polytherapy. J Int Neuropsychol Soc 17:133–142
Nadebaum C, Anderson VA, Vajda F, Reutens DC, Barton S, Wood AG (2011b) Language skills of school-aged children prenatally exposed to antiepileptic drugs. Neurology 76:719–726
Nicolai J, Vles JSH, Aldenkamp AP (2008) Neurodevelopmental delay in children exposed to antiepileptic drugs in utero: a critical review directed at structural study basis. J Neurol Sci 271:1–14
Palac S, Meador KJ (2011) Aeds and neurodevelopment: an update. Curr Neurol Neurosci Rep 11:423–427
Pulliainen V, Jokelainen M (1994) Effects of phenytoin and carbamazepine on cognitive functions in newly diagnosed epileptic patients. Acta Neurol Scand 89:81–86
Pulliainen V, Jokelainen M (1995) Comparing the cognitive effects of phenytoin and carbamazepine in long-term monotherapy: a two-year follow-up. Epilepsia 36:1195–1202
Rasalam AD, Hailey H, Williams JH, Moore SJ, Turnpenny PD, Lloyd DJ, Dean JC (2005) Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Dev Med Child Neurol 47:551–555
Reinisch JM, Sanders SA, Mortensen EL, Rubin DB (1995) In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA 274:1518–1525
Rogel-Fuchs Y, Newman ME, Trombka D, Zahalka EA, Yanai J (1992) Hippocampal cholinergic alterations and related behavioral deficits after early exposure to phenobarbital. Brain Res Bull 29:1–6
Sattler JM (1992) Assessment of children’s intelligence and special abilities. Allyn & Bacon, Boston
Schain RJ, Watanabe K (1975) Effect of chronic phenobarbital administration upon brain growth of the infant rat. Exp Neurol 47:509–515
Scolnik D, Nulman I, Rovet J et al (1994) Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. JAMA 271:767–770. Erratum in JAMA (1994); 271:1745
Shallcross R, Bromley RL, Irwin B et al (2011) Child development following in utero exposure: levetiracetam vs sodium valproate. Neurology 76:383–389
Smith DB, Craft BR, Collins J et al (1986) Behavioral characteristics of epilepsy patients compared with normal controls. Epilepsia 27:760–768
Smith KR Jr, Goulding PM, Wilderman D et al (1994) Neurobehavioral effects of phenytoin and carbamazepine in patients recovering from brain trauma: a comparative study. Arch Neurol 51:653–660
Stefovska VG, Uckermann O, Czuczwar M et al (2008) Sedative and anticonvulsant drugs suppress postnatal neurogenesis. Ann Neurol 64:434–445
Tomson T, Klein P (2015) Fine-tuning risk assessment with antiepileptic drug use in pregnancy. Neurology 84:339–340
Vajda FJE, O’Brien T, Hitchcock A, Graham J, Lander C, Eadie M (2007) The Australian antiepileptic drug in pregnancy register: aspects of data collection and analysis. J Clin Neurosci 14:936–942
Vajda FJE, O’Brien TJ, Lander CM, Graham J, Eadie MJ (2014) The teratogenicity of the newer antiepileptic drugs – an update. Acta Neurol Scand 130:234–238
Vanoverloop D, Schnell RR, Harvey EA, Holmes LB (1992) The effects of prenatal exposure to phenytoin and other anticonvulsants on intellectual function at 4 to 8 years of age. Neurotoxicol Teratol 14:329–335
Wide K, Henning E, Tomson T, Winbladh B (2002) Psychomotor development in preschool children exposed to antiepileptic drugs in utero. Acta Paediatr 91:409–414
Williams G, King J, Cunningham M, Stephan M, Kerr B, Hersh JH (2001) Fetal valproate syndrome and autism: additional evidence of an association. Dev Med Child Neurol 43:202–206
Wood AG, Chen J, Barton S et al (2014) Altered cortical thickness following prenatal sodium valproate exposure. Ann Clin Transl Neurol 1:497–501
Wood AG, Nadebaum C, Anderson VA, Reutens DC, Barton S, O’Brien TJ, Vajda FJE (2015) Prospective assessment of autism traits in children exposed to antiepileptic drugs during pregnancy. Epilepsia 56:1047–1055
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Eadie, M., Vajda, F. (2016). Antiepileptic Drugs, Cognition and Neurodevelopment. In: Antiepileptic Drugs and Pregnancy. Adis, Cham. https://doi.org/10.1007/978-3-319-21434-4_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-21434-4_10
Publisher Name: Adis, Cham
Print ISBN: 978-3-319-21433-7
Online ISBN: 978-3-319-21434-4
eBook Packages: MedicineMedicine (R0)